The global market for Parenteral Nutrition is estimated at US$7.5 Billion in 2023 and is projected to reach US$11.8 Billion by 2030, growing at a CAGR of 6.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth of PN, particularly Home Parenteral Nutrition (HPN), is driven by several key factors. Innovations in infusion pumps and catheter designs have made PN more user-friendly and safer, encouraging broader adoption. The shift towards home care settings, driven by the need to reduce hospital stays and healthcare costs, has expanded the application of PN outside traditional hospital environments. PN`s integration into palliative care enhances the quality of life for patients with severe illnesses who cannot meet their nutritional needs through oral intake alone. Additionally, the aging population, which often faces swallowing difficulties or digestive issues, increases the demand for PN. Increased patient advocacy and awareness, supportive regulatory policies, and expanded insurance and reimbursement coverage also drive the growth and adoption of PN. These factors collectively reflect changes in healthcare systems, technological advancements, and patient preferences, indicating a continued evolution and expansion of PN across various healthcare settings.
The growth of PN, particularly Home Parenteral Nutrition (HPN), is driven by several key factors. Innovations in infusion pumps and catheter designs have made PN more user-friendly and safer, encouraging broader adoption. The shift towards home care settings, driven by the need to reduce hospital stays and healthcare costs, has expanded the application of PN outside traditional hospital environments. PN`s integration into palliative care enhances the quality of life for patients with severe illnesses who cannot meet their nutritional needs through oral intake alone. Additionally, the aging population, which often faces swallowing difficulties or digestive issues, increases the demand for PN. Increased patient advocacy and awareness, supportive regulatory policies, and expanded insurance and reimbursement coverage also drive the growth and adoption of PN. These factors collectively reflect changes in healthcare systems, technological advancements, and patient preferences, indicating a continued evolution and expansion of PN across various healthcare settings.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Single Dose Amino Acid Solution segment, which is expected to reach US$4.1 Billion by 2030 with a CAGR of a 7.0%. The Parenteral Lipid Emulsion segment is also set to grow at 7.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.0 Billion in 2023, and China, forecasted to grow at an impressive 10.3% CAGR to reach $2.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Parenteral Nutrition Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Parenteral Nutrition Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Parenteral Nutrition Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Allergan plc, Amanta Healthcare Ltd, B. Braun Melsungen AG, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 36 Featured):
- Allergan plc
- Amanta Healthcare Ltd
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius KABI AG
- Grifols International S.A.
- ICU Medical Inc.
- Otsuka Pharmaceutical Factory Inc.
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Sino-Swed Pharmaceutical Corp. Ltd.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- Allergan plc
- Amanta Healthcare Ltd
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius KABI AG
- Grifols International S.A.
- ICU Medical Inc.
- Otsuka Pharmaceutical Factory Inc.
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Sino-Swed Pharmaceutical Corp. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 272 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 7.5 Billion |
| Forecasted Market Value ( USD | $ 11.8 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
